The Collaborative Research Award seeks to foster collaborative approaches to research projects that propose novel pairings of investigators from at least two broadly different disciplines. The combination and integration of studies may be inclusive of basic, clinical, population, behavioral, and/or translational research.
Research priorities include evidence-based strategies for improving treatment adherence; early and accurate identification of acute cellular and antibody-mediated rejection and cardiac allograft vasculopathy, including the development of accurate non-invasive methods and strategies for surveillance; studies on the causes, prevention, and treatment of cardiac allograft vasculopathy; and strategies to improve the viability of donor hearts and the development of novel immunotherapies by the identification of novel targets by improving the side-effect profiles of immunotherapies and/or by improving methods for monitoring the level of immunosuppression. Applications for the development of new technologies that would address any of these priority areas will also be considered.
Grants of up to $681,819 over three years will be awarded.
Proposals are encouraged from all basic science disciplines as well as epidemiological, behavioral, community, and clinical investigations that bear on pediatric heart transplantation. Awards are open to the array of academic and health professionals, including but not limited to all academic disciplines (biology, chemistry, engineering, mathematics, technology, immunology, physiology, etc.) and all health-related professions (physicians, nurses, advanced practice nurses, pharmacists, dentists, physical and occupational therapists, statisticians, nutritionists, behavioral scientists, health attorneys, biomedical engineers, psychologists, etc.)
To be eligible, at least one co-PI must work in research directly related to pediatric heart transplantation; at least one co-PI must work in a different discipline (e.g., engineering, computer science, chemistry, mathematics, psychology, health law, genomics/genetics, etc.) and/or not have a prior focus in clinical pediatric heart transplantation; at least one co-PI must be an early-career (assistant professor or equivalent) or mid-career (associate professor or equivalent) investigator; and co-PIs must each hold faculty/staff appointments and an MD, PhD, DO, DDS, DVM or equivalent post-baccalaureate terminal (highest-level) degree in his/her discipline.
Letters of Intent are due October 1. Upon review, selected applicants will be invited to submit a full proposal by January 15, 2021.
See the American Heart Association website for complete program guidelines and application instructions.